Unknown OBSERVATIONAL NCT03314818

Natural History of Carotid Plaque as Determined by 3D Ultrasound (BioImage2)

BioImage 2: Long-Term Follow-up of BioImage Study Cohort to Investigate Natural History of Carotid Plaque as Determined by 3D Ultrasound

Sponsor: AstraZeneca

Conditions Atherosclerotic Disease Cardiovascular Risk Factor Heart Diseases Plaque, Atherosclerotic Stroke

Interventions Ultrasound 3D Imaging

Updated 7 times since 2017 Last updated: Oct 16, 2017 Started: Sep 22, 2017 Primary completion: Sep 22, 2018 Completion: Oct 22, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Atherosclerotic Disease and Cardiovascular Risk Factor, this trial is ongoing. The trial is conducted by AstraZeneca and has accumulated 7 data snapshots since 2017. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Nov 2023 — Jul 2024 [monthly]

Unknown Status

Status: Enrolling By Invitation → Unknown Status
Jan 2021 — Nov 2023 [monthly]

Enrolling By Invitation
Feb 2020 — Jan 2021 [monthly]

Enrolling By Invitation

▶ Show 2 earlier versions

Apr 2018 — Feb 2020 [monthly]

Enrolling By Invitation

Phase: NA → None
Nov 2017 — Apr 2018 [monthly]

Enrolling By Invitation NA

First recorded

Sep 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AstraZeneca
Icahn School of Medicine at Mount Sinai
Pieter Muntendam

Data source: BioImage-2 LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lauderhill, United States